Page 13 - தற்போதைய நல்ல உற்பத்தி ப்ர்யாக்டீஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
FDA Continues to Referee the CBD Market
natlawreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from natlawreview.com Daily Mail and Mail on Sunday newspapers.
Columbia Basin Bioscience gains certification
eastoregonian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eastoregonian.com Daily Mail and Mail on Sunday newspapers.
New cell therapy program will take ideas from lab to factory floor
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
New Superior Enzymes and Customised Purification Resins for Biopharma and Regenerative Medicines
pharmaceutical-business-review.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmaceutical-business-review.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global diuretics drugs market is expected to decline from $0.9 billion in 2019 to $0.8 billion in 2020 at a compound annual growth rate (CAGR) of -17.9%.
Diuretics Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global diuretics drugs market as it emerges from the COVID-19 shut down.
The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 5.8% from 2021 and reach $1.1 billion in 2023.